Hot Stock Movers On FDA Decision (CTIC, IDRA, INO,JNJ)

Cordis Corporation, a Johnson & Johnson (NYSE: JNJ) company, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT, to treat abdominal aortic aneurysm (AAA).

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled “A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis” (abstract P259) was made by Idera scientists at the American Heart Association conference “Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions” being held April 8-10 in San Francisco, CA.

Inovio Biomedical Corporation (AMEX: INO) announced today that the company and its collaborators from Drexel University, Cheyney University, and the University of Pennsylvania have received a $2.8 million grant to develop a DNA vaccine to treat hepatitis C virus (HCV).

Cell Therapeutics, Inc. (NASDAQ: CTIC) today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration (the "FDA") regarding its New Drug Application ("NDA") for Pixuvri (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks ,most active movers, top gainers, hot penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.